1-5 of 5
Susan G. Hilsenbeck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer

Available to Purchase
Adelaide Young, Wen Bu, Weiyu Jiang, Amy Ku, Jyoti Kapali, Sagar Dhamne, Lan Qin, Susan G. Hilsenbeck, Yi-Chieh Nancy Du, Yi Li
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (1): 3–10.
https://doi.org/10.1158/1940-6207.CAPR-21-0031
Published: 06 January 2022
View article titled, Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer
Open the PDF for Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A42: Autocrine-produced IL-6 and IL-8 are essential for the growth and maintenance of the transformed phenotype of basal-like breast cancer cells

Free
Zachary C. Hartman, Anna Tsimelzon, Jamal Hill, Yun Zhang, Abhijit Mazumdar, Susan G. Hilsenbeck, Gordon Mills, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A42.
https://doi.org/10.1158/1940-6207.PREV-11-A42
Published: 23 October 2014
View article titled, Abstract A42: Autocrine-produced IL-6 and IL-8 are essential for the growth and maintenance of the transformed phenotype of basal-like breast cancer cells
Journal Articles

Abstract A54: Combining the rexinoid bexarotene with tamoxifen to prevent ER‐negative mammary tumors in MMTV‐erbB2 mice

Free
Abhijit Mazumdar, Yun Zhang, Powel H. Brown, Susan G. Hilsenbeck, Reid Bissonnette
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (1_Supplement): A54.
https://doi.org/10.1158/1940-6207.PREV-09-A54
Published: 21 October 2014
View article titled, Abstract A54: Combining the rexinoid bexarotene with tamoxifen to prevent ER‐negative mammary tumors in MMTV‐erbB2 mice
Journal Articles

Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib

Free
Daniel Medina, Frances Kittrell, Jamal Hill, Yun Zhang, Susan G. Hilsenbeck, Reid Bissonette, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (2): 168–174.
https://doi.org/10.1158/1940-6207.CAPR-08-0107
Published: 05 February 2009
View article titled, Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib
Open the PDF for Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib in another window
Includes: Supplementary data
Journal Articles

Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor–Negative Mammary Tumors

Free
Qiang Shen, Ivan P. Uray, Yuxin Li, Yun Zhang, Jamal Hill, Xiao-Chun Xu, Matthew R. Young, Edward J. Gunther, Susan G. Hilsenbeck, Nancy H. Colburn, Lewis A. Chodosh, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (1): 45–55.
https://doi.org/10.1158/1940-6207.CAPR-08-0034
Published: 09 June 2008
View article titled, Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor–Negative Mammary Tumors
Open the PDF for Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor–Negative Mammary Tumors in another window